Literature DB >> 9190065

Codon bias and plasticity in immunoglobulins.

T B Kepler1.   

Abstract

Immunoglobulin genes experience Darwinian evolution twice. In addition to the germline evolution all genes experience, immunoglobulins are subjected, upon exposure to antigen, to somatic hypermutation. This is accompanied by selection for high affinity to the eliciting antigen and frequently results in a significant increase in the specificity of the responding population. The hypermutation mechanism displays a strong sequence specificity. Thus arises the opportunity to manipulate codon bias in a site-specific manner so as to direct hypermutation to those parts of the gene that encode the antigen-binding portions of the molecule and away from those that encode the structurally conserved regions. This segregation of mutability would clearly be advantageous; it would enhance the generation of potentially useful variants while keeping mutational loss to acceptably low levels. But it is not clear that the advantage gained would be large enough to produce a measurable effect within the background stochasticity of the evolutionary process. I have performed a pair of statistical tests to determine whether site-specific codon bias in human immunoglobulin genes is correlated with the sequence specificity of the somatic mutation mechanism. The sequence specificity of the mutator was determined by analysis of a database of published immunoglobulin intron sequences that had experienced somatic mutation but not selection. The site-specific codon bias was determined by analysis of published sequences of human germline immunoglobulin V genes. Both tests strongly suggest that evolution has acted to enhance the plasticity of immunoglobulin genes under somatic hypermutation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190065     DOI: 10.1093/oxfordjournals.molbev.a025803

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  21 in total

1.  Evolvability is a selectable trait.

Authors:  David J Earl; Michael W Deem
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

2.  Modulation of base-specific mutation and recombination rates enables functional adaptation within the context of the genetic code.

Authors:  Taison Tan; Leonard D Bogarad; Michael W Deem
Journal:  J Mol Evol       Date:  2004-09       Impact factor: 2.395

3.  Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.

Authors:  Roshini S Abraham; Michelle K Manske; Neta S Zuckerman; Abhishek Sohni; Hanna Edelman; Gitit Shahaf; Michael M Timm; Angela Dispenzieri; Morie A Gertz; Ramit Mehr
Journal:  J Clin Immunol       Date:  2006-12-28       Impact factor: 8.317

4.  Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation.

Authors:  Uri Hershberg; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

5.  B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions.

Authors:  Jasmine Saini; Uri Hershberg
Journal:  Mol Immunol       Date:  2015-02-06       Impact factor: 4.407

6.  Genetic plasticity of V genes under somatic hypermutation: statistical analyses using a new resampling-based methodology.

Authors:  M Oprea; T B Kepler
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

Review 7.  Related Mechanisms of Antibody Somatic Hypermutation and Class Switch Recombination.

Authors:  Joyce K Hwang; Frederick W Alt; Leng-Siew Yeap
Journal:  Microbiol Spectr       Date:  2015-02

8.  Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity.

Authors:  Wenzhong Guo; Diana Smith; Katja Aviszus; Thiago Detanico; Ryan A Heiser; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

9.  B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors:  Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

10.  Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID.

Authors:  Meng Wang; Cristina Rada; Michael S Neuberger
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.